Cargando…

Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test

BACKGROUND: Mass-like (ML) and non-mass-like (NML) are two manifestations of breast lesions on ultrasound. Contrast-enhanced ultrasound (CEUS) can make up for the limitation of B-ultrasound (US) in the observation of focal blood flow, and shear wave elastography (SWE) can supplement the hardness inf...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shi-Yu, Niu, Rui-Lan, Wang, Bo, Jiang, Ying, Li, Jia-Nan, Liu, Gang, Wang, Zhi-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005981/
https://www.ncbi.nlm.nih.gov/pubmed/36915819
http://dx.doi.org/10.21037/gs-23-51
_version_ 1784905210434420736
author Li, Shi-Yu
Niu, Rui-Lan
Wang, Bo
Jiang, Ying
Li, Jia-Nan
Liu, Gang
Wang, Zhi-Li
author_facet Li, Shi-Yu
Niu, Rui-Lan
Wang, Bo
Jiang, Ying
Li, Jia-Nan
Liu, Gang
Wang, Zhi-Li
author_sort Li, Shi-Yu
collection PubMed
description BACKGROUND: Mass-like (ML) and non-mass-like (NML) are two manifestations of breast lesions on ultrasound. Contrast-enhanced ultrasound (CEUS) can make up for the limitation of B-ultrasound (US) in the observation of focal blood flow, and shear wave elastography (SWE) can supplement the hardness information of the lesion. The present study aimed to analyze the characteristic manifestations of US, CEUS, and SWE in NML and ML breast and evaluate whether the diagnostic performance of these three ultrasound techniques differs in terms of differentiating between benign and malignant breast lesions. METHODS: From January to August 2021, 382 patients (417 breast lesions) underwent US, CEUS, and SWE examinations. Of these, 204 women (218 breast lesions) were included in our study due to subsequent biopsy or surgery with pathological findings. The patients were divided into ML and NML groups according to the ultrasound characteristics, and the differences in multimodal ultrasound performance between benign and malignant NML and benign and malignant ML breast lesions were compared. The diagnostic performance of US, US + CEUS, US + SWE, US + CEUS + SWE for ML, NML and all breast lesions was evaluated by analyzing sensitivity, specificity and area under receiver operating characteristic (ROC) curve (AUC). RESULTS: Pathologically, the 218 lesions included 96 malignant and 122 benign breast lesions. The sensitivity and specificity of US + CEUS + SWE in all lesion groups, ML group and NML group were 92.7% and 90.2%, 95.9% and 90.3%, 91.3% and 79.3%, respectively. In all breast group, AUCs of US + CEUS, US + SWE, US + CEUS + SWE were statistically different from AUC of US (P=0.0010, 0.0001, 0.0001). In the ML group, the AUC of US + CEUS, US + SWE, US + CEUS + SWE were statistically different from that of US (P=0.0120, 0.0008, 0.0002). In the NML group, there was a statistical difference between US + SWE and US AUC (P=0.0149). CONCLUSIONS: US, CEUS, and SWE have an important diagnostic value for benign and malignant ML and NML breast lesions. Multimodal ultrasound combined with US, CEUS, and SWE can improve the diagnostic efficacy in distinguishing between benign and malignant ML and NML lesions.
format Online
Article
Text
id pubmed-10005981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-100059812023-03-12 Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test Li, Shi-Yu Niu, Rui-Lan Wang, Bo Jiang, Ying Li, Jia-Nan Liu, Gang Wang, Zhi-Li Gland Surg Original Article BACKGROUND: Mass-like (ML) and non-mass-like (NML) are two manifestations of breast lesions on ultrasound. Contrast-enhanced ultrasound (CEUS) can make up for the limitation of B-ultrasound (US) in the observation of focal blood flow, and shear wave elastography (SWE) can supplement the hardness information of the lesion. The present study aimed to analyze the characteristic manifestations of US, CEUS, and SWE in NML and ML breast and evaluate whether the diagnostic performance of these three ultrasound techniques differs in terms of differentiating between benign and malignant breast lesions. METHODS: From January to August 2021, 382 patients (417 breast lesions) underwent US, CEUS, and SWE examinations. Of these, 204 women (218 breast lesions) were included in our study due to subsequent biopsy or surgery with pathological findings. The patients were divided into ML and NML groups according to the ultrasound characteristics, and the differences in multimodal ultrasound performance between benign and malignant NML and benign and malignant ML breast lesions were compared. The diagnostic performance of US, US + CEUS, US + SWE, US + CEUS + SWE for ML, NML and all breast lesions was evaluated by analyzing sensitivity, specificity and area under receiver operating characteristic (ROC) curve (AUC). RESULTS: Pathologically, the 218 lesions included 96 malignant and 122 benign breast lesions. The sensitivity and specificity of US + CEUS + SWE in all lesion groups, ML group and NML group were 92.7% and 90.2%, 95.9% and 90.3%, 91.3% and 79.3%, respectively. In all breast group, AUCs of US + CEUS, US + SWE, US + CEUS + SWE were statistically different from AUC of US (P=0.0010, 0.0001, 0.0001). In the ML group, the AUC of US + CEUS, US + SWE, US + CEUS + SWE were statistically different from that of US (P=0.0120, 0.0008, 0.0002). In the NML group, there was a statistical difference between US + SWE and US AUC (P=0.0149). CONCLUSIONS: US, CEUS, and SWE have an important diagnostic value for benign and malignant ML and NML breast lesions. Multimodal ultrasound combined with US, CEUS, and SWE can improve the diagnostic efficacy in distinguishing between benign and malignant ML and NML lesions. AME Publishing Company 2023-02-24 2023-02-28 /pmc/articles/PMC10005981/ /pubmed/36915819 http://dx.doi.org/10.21037/gs-23-51 Text en 2023 Gland Surgery. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Li, Shi-Yu
Niu, Rui-Lan
Wang, Bo
Jiang, Ying
Li, Jia-Nan
Liu, Gang
Wang, Zhi-Li
Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title_full Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title_fullStr Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title_full_unstemmed Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title_short Determining whether the diagnostic value of B-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
title_sort determining whether the diagnostic value of b-ultrasound combined with contrast-enhanced ultrasound and shear wave elastography in breast mass-like and non-mass-like lesions differs: a diagnostic test
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005981/
https://www.ncbi.nlm.nih.gov/pubmed/36915819
http://dx.doi.org/10.21037/gs-23-51
work_keys_str_mv AT lishiyu determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT niuruilan determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT wangbo determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT jiangying determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT lijianan determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT liugang determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest
AT wangzhili determiningwhetherthediagnosticvalueofbultrasoundcombinedwithcontrastenhancedultrasoundandshearwaveelastographyinbreastmasslikeandnonmasslikelesionsdiffersadiagnostictest